Jun, S.Y.; Yoon, H.R.; Yoon, J.-Y.; Jeon, S.-J.; Lee, J.-J.; Halder, D.; Kim, J.-M.; Kim, N.-S.
The Human TOR Signaling Regulator Is the Key Indicator of Liver Cancer Patients’ Overall Survival: TIPRL/LC3/CD133/CD44 as Potential Biomarkers for Early Liver Cancers. Cancers 2021, 13, 2925.
https://doi.org/10.3390/cancers13122925
AMA Style
Jun SY, Yoon HR, Yoon J-Y, Jeon S-J, Lee J-J, Halder D, Kim J-M, Kim N-S.
The Human TOR Signaling Regulator Is the Key Indicator of Liver Cancer Patients’ Overall Survival: TIPRL/LC3/CD133/CD44 as Potential Biomarkers for Early Liver Cancers. Cancers. 2021; 13(12):2925.
https://doi.org/10.3390/cancers13122925
Chicago/Turabian Style
Jun, Soo Young, Hyang Ran Yoon, Ji-Yong Yoon, Su-Jin Jeon, Jeong-Ju Lee, Debasish Halder, Jin-Man Kim, and Nam-Soon Kim.
2021. "The Human TOR Signaling Regulator Is the Key Indicator of Liver Cancer Patients’ Overall Survival: TIPRL/LC3/CD133/CD44 as Potential Biomarkers for Early Liver Cancers" Cancers 13, no. 12: 2925.
https://doi.org/10.3390/cancers13122925
APA Style
Jun, S. Y., Yoon, H. R., Yoon, J. -Y., Jeon, S. -J., Lee, J. -J., Halder, D., Kim, J. -M., & Kim, N. -S.
(2021). The Human TOR Signaling Regulator Is the Key Indicator of Liver Cancer Patients’ Overall Survival: TIPRL/LC3/CD133/CD44 as Potential Biomarkers for Early Liver Cancers. Cancers, 13(12), 2925.
https://doi.org/10.3390/cancers13122925